Guidelines for Co‑prescribing Azithromycin and Antidepressants: Cardiac and Metabolic Considerations
QT‑Prolongation Risk
Citalopram and escitalopram should be avoided when azithromycin is prescribed because they have the highest QT‑interval prolongation risk among SSRIs, especially in patients with baseline QTc ≥ 450 ms, older adults, or females. Strength of evidence: observational data from pediatric and adolescent psychiatry studies. [1][2]
Tricyclic antidepressants (TCAs) markedly increase QT interval and cardiac‑arrest risk (odds ratio ≈ 1.69) when combined with azithromycin; therefore, co‑administration should be avoided. Strength of evidence: cohort analysis published in a cardiovascular journal. 3
Safer Antidepressant Options
Sertraline is considered low‑risk for QT prolongation and shows minimal CYP450 interaction with azithromycin, making it a preferred SSRI in this context. Strength of evidence: pharmacologic profiling from adolescent psychiatry literature. 1
Paroxetine does not significantly prolong the QT interval; its CYP2D6 inhibition is not relevant to azithromycin metabolism, supporting its safety as an alternative SSRI. Strength of evidence: same pharmacologic profiling as above. 1
Cardiac Monitoring Recommendations
Baseline electrocardiogram (ECG) should be obtained for patients with any of the following risk factors before starting azithromycin: age > 60 years, female sex, structural heart disease, electrolyte disturbances, or concurrent diuretic therapy. Strength of evidence: risk‑assessment guideline derived from cardiovascular research. 3
If baseline QTc is 450–499 ms, serial QTc monitoring is advised during azithromycin therapy, and both drugs should be discontinued if QTc exceeds 500 ms. Strength of evidence: clinical monitoring protocol from adolescent psychiatry studies. 2
Serotonin‑Syndrome Considerations
The risk of serotonin syndrome with azithromycin is theoretical and minimal because azithromycin lacks serotonergic activity; the primary concern remains the combination of multiple serotonergic agents (e.g., SSRIs + MAOIs, tramadol, dextromethorphan). Strength of evidence: expert consensus from psychiatric literature. [4][1]2
Monoamine‑oxidase inhibitors (MAOIs) are contraindicated with any serotonergic medication but have no specific interaction with azithromycin beyond the general serotonin‑syndrome precaution. Strength of evidence: consensus recommendation. 1
Fluvoxamine should be avoided not because of azithromycin interaction but due to its extensive CYP pathway inhibition, which poses a high overall drug‑interaction risk. Strength of evidence: pharmacologic review. [1][2]